Slovenian Intellectual Property Office | SIPO Database Server Guide |
![]() |
Patent in force | |||||
(51) | Int. Cl.: |
| |||
(11) | Publication Number: | 2203462 | |||
(21) | Application Number: | 200831244 | |||
(22) | Application Date: | 26.03.2008 | |||
(86) | PCT Application: | 26.03.2008 WO PCT/US2008/058183 | |||
(96) | EP Application: | 26.03.2008 EP 08732818.3 European patent register | |||
(87) | PCT Publication: | WO 2008/121634, 09.10.2008 Patentscope | |||
(97) | EP Publication: |
EP 2203462 B1, 21.05.2014 European publication server PDF EP 2203462 B2, 25.09.2024 European publication server PDF | |||
(30) | Priority: | 30.03.2007 US 909315; 24.10.2007 US 982309; 21.03.2008 US 53015 | |||
(46) | Claims Published: | 30.09.2014 (T1 - Translation of claims of European patent) PDF | |||
(72) | Inventor: | SOFIA Michael Joseph, Doylestown, PA 18902, US (United States); DU Jinfa, New Hope, PA 18938, US (United States); WANG Peiyuan, Glen Rock, NJ 07452, US (United States); NAGARATHNAM Dhanapalan, Bethany, CT 06524, US (United States) | |||
(73) | Owner: | Gilead Pharmasset LLC, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, US (United States) | |||
(74) | Representative: | Marjan Pipan, inz. el., Kotnikova 5, 1000 Ljubljana, SI (Slovenia) | |||
(54) | Title: | NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS | |||
Additional information: | |||||
Filed by SIPO on 18.07.2014 | |||||
SPC request date: 17.11.2014 | |||||
SPC application(s): 201440043 | |||||
Renewal fee for the patent for the 19th year is due on 26.03.2026 |